Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Ultomiris 300 mg/3 mL concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
ravulizumab
Company:  
Alexion Pharma UK Ltd See contact details
ATC code: 
L04AA43
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) User Manual Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

The user manual gives instructions on how to safely and effectively administer your medicine. It should be read in conjunction with the patient leaflet.

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.


{pdf} View or print the user manual as PDF
Alexion Pharma UK Ltd
Company image
Address
2 Pancras Square, London, N1C 4AG, UK
Telephone
+44 (0) 208 744 6600
Fax
+44 (0) 20 8744 6630
Medical Information Direct Line
0800 028 4394
Medical Information e-mail
[email protected]
Customer Care direct line
0800 1300 212